ANN ARBOR, MICH. - November 20, 2025 - FOR IMMEDIATE RELEASE 
Genomenon, Inc., an AI-driven genomics company, today announced the appointment of Kristin Fix as Senior Vice President of Sales. With more than two decades of experience building and leading commercial organizations in Life Sciences - including senior executive roles at Inovalon and Symphony Health, Fix will lead Genomenon’s global sales strategy as the company scales its leadership in the rapidly growing literature-derived Real-World Evidence (RWE) market.

Historically, RWE has largely meant electronic health records (EHR), registry, and claims data. Genomenon takes a different approach - using AI and expert curation to systematically extract and structure patient-level evidence from the scientific literature into clean, clinically relevant datasets that illuminate how patients actually present, progress, and respond to treatment. This literature-derived real-world evidence fills the gaps left by EHR and claims data, giving rare disease and oncology teams the complete genomic and phenotypic context needed to design better trials, strengthen regulatory packages, and expand the reach of targeted therapies.

With more than 75 RWE programs delivered for over 25 pharmaceutical partners, Genomenon’s literature-derived platform is already informing indication strategy, patient cohort discovery, and evidence generation. Fix’s leadership will further accelerate the company’s expansion with top-tier pharma and biopharma organizations, leveraging her deep domain expertise and proven track recor

ANN ARBOR, MI, UNITED STATES, – GreenMark Biomedical Inc., a pioneer in leveraging biomimetic technology for dental health innovations…………

Genomenon Genomic Graph (G3) knowledgebase combines patient and biological data from nearly all published scientific and medical studies, including demographics, clinical characteristics, phenotypes, treatments, outcomes, and disease-associated genes and variants.

‍

●      Training of the underlying large language model (LLM) for G3 uses Genomenon’s proprietary, expertly curated genomic datasets to deliver unprecedented model accuracy 

‍

●      The knowledgebase will power AI-driven predictive models of unparalleled accuracy, breadth, and complexity for clinical diagnostics and drug development applications 

‍

Ann Arbor, MI – December 17, 2024 – Genomenon, Inc., a leading provider of genomic intelligence solutions, today announced the company has used the industry’s most advanced genomic AI platform to build the Genomenon Genomic Graph (G3) knowledgebase of all clinically relevant, empirical genomic evidence. This advancement represents the first time that content from the entire corpus of clinically relevant literature will be captured in a single, searchable knowledgebase. 

‍

The knowledgebase will include genes, genetic variants, copy number variants, structural variants including fusion events, gene-disease relationships, drugs, phenotypes, and patient demographics and symptoms derived from the indexed content of the published scientific research. In addition to enabling advanced biomedical literature search and aler